News
Kodiak Sciences Selects Advarra for IRB Services and Technology Partner for Ophthalmology Clinical Trials
Kodiak Sciences selected Advarra for IRB services to enhance efficiency & compliance in its retinal disease clinical trials, leveraging Advarra's CIRBI platform.
In the News: Decentralized Clinical Trials- Bust or Breakthrough?
Five industry leaders provide their perspectives on how these types of studies are evolving and their impact on the research industry.
Advarra Ranks on Inc. 5000 List of Fastest-Growing Private Companies
Advarra announced its inclusion on the Inc. 5000 list for 2024.
Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrollment
New capability provides sponsors and CROs holistic view of sites’ patient recruitment progress
Connecting the Clinical Ecosystem to Alleviate Site Burden
The future is a connected user experience with automated workflows and transparency to accelerate studies without compromising compliance.
In The News: The FDA pushes concrete plans to further diversity in clinical trials
The FDA's draft guidance mandates Diversity Action Plans for phase 3 trials to address past underrepresentation adds complexity for sponsors.
In The News: Industry Leaders Discuss the Impact of FDA’s Diversity Action Plan
Luke Gelinas and other experts highlight the potential impact FDA's Diversity Action Plan guidance will have on industry.
In The News: Friction From Technology In Clinical Research
The clinical trial landscape faces challenges like patient recruitment and workforce shortages, making streamlined technology essential.
In the News: Current State of Sustainability in Clinical Research
Applied Clinical Trials held an expert roundtable event focused on the current state of sustainability in clinical research.
In The News: For Faster Trials, Improve Feasibility
Improving trial feasibility through better collaboration and automation can significantly accelerates timelines and mitigate common issues.
In The News: Clinical Trial Feasibility Podcast
Christine Senn highlights the importance of thorough feasibility processes in rare disease trials. The need for diverse site participation and data inputs to improve trial accuracy and efficiency. The role ...
In the News: A Pragmatic Approach To Technology In Clinical Research
In 2023, the FDA approved 55 new drugs and five gene therapies for rare diseases. Yet, there has been little progress in accelerating development timelines.